Nkarta, Inc.: H.C. Wainwright assumes coverage with buy rating; price target $12
NKTX•H.C. Wainwright assumed coverage of Nkarta, Inc. with a buy rating and a $12 price target.
Related News
PSEG Q3 adjusted operating earnings USD 574 million
PEG•
Cytokinetics announces three aficamten presentations at HCMS Scientific Sessions
CYTK•
Arch Capital Group raises target price to $119 from $107
ACGL•
Immunome to present at Guggenheim 3rd Annual Healthcare Innovation Conference
IMNM•
Shard Capital sees Arista Networks, Everpure benefiting from Meta's AI spending
ANET•